Dr. David S. Cantor, Ph.D., M.Sc., QEEG-DL, BCN, FNAN is a globally recognized leader in neuroscience, quantitative electrophysiology, and clinical neurotechnology. With over four decades of leadership spanning academic research, clinical operations, forensic consulting, and executive management, Dr. Cantor has served as CEO, Board Director, and Scientific Advisor to major organizations in health technology and applied neuroscience.

His expertise includes quantitative EEG (qEEG) development, neurodiagnostics, psychopharmacology, regulatory advisory, strategic leadership, and product innovation. He has authored numerous peer-reviewed publications and chapters, served on international boards, and received multiple career achievement awards. Dr. Cantor is known for bridging rigorous scientific knowledge with applied clinical and corporate innovation.

Detailed CV Found here

PROFESSIONAL EXPERIENCE

President & CEO — BrainDx, LLC

2004 – 2024
Directed international neurotechnology company providing qEEG-based diagnostic software and services worldwide. Oversaw strategic partnerships, R&D, regulatory strategy, and corporate growth.

President — Mind & Motion, LLC

2016 – Present
Led integrated behavioral health and neurodevelopmental clinical service organization.

Board of Directors — International QEEG Certification Board

2021 – Present
Guided international credentialing and certification standards for qEEG practitioners.

Board of Directors — NeuroTech Inc.

2018 – 2020
Strategic advisory for emerging neurotechnology solutions.

President — Psychological Sciences Institute

1995 – 2015
Directed multidisciplinary neuropsychological and EEG clinical services for pediatric and adult populations.

Director, Dept. of Neuropsychology — Scottish Rite Children’s Medical Center

1994 – 1995
Founded and managed neuropsychology department; supervised staff; established accreditation programs.

Staff Neuropsychologist — Meadowbrook Rehabilitation Corporation

1991 – 1993
Neuropsychological assessments and rehabilitation program development for subacute and transitional care patients.

BOARD & LEADERSHIP ROLES

• Board of Directors – International QEEG Certification Board (2021–Present)
• Board of Directors – NeuroTech Inc. (2018–2020)
• President & Treasurer – EEG and Clinical Neuroscience Society (2005–2009)
• Founding Board – International Board of Quantitative Electrophysiology (Chair 2018–2020)
• Board of Advisors – International Society of Neuroregulation and Research (2020–Present)
• Board of Directors – Southeast Biofeedback and Clinical Neuroscience Association (2012–2017)
• Board of Directors – Alexsander Academy (2011–2017)

EDUCATION & CERTIFICATIONS

Ph.D., Psychology – SUNY Stony Brook (1983)

M.A., Psychology – SUNY Stony Brook (1979)

B.A., Psychology (Cum Laude) – University of Connecticut (1977)

Postdoctoral M.Sc., Clinical Psychopharmacology – Farleigh Dickinson University (2009)

Postgraduate Certificate Series in Neurophysiology, Neuroanatomy, Pathophysiology, and Clinical Pharmacology – University of Georgia School of Pharmacy (2000–2002)

• Licensed Psychologist – GA, MD (Active), DC (Inactive)
• Board Certified QEEG-DL
• BCIA Certified – Neurofeedback
• Diplomate, International Board of Quantitative Electrophysiology
• ECNS Board Certified in EEG/QEEG and Clinical Neuroscience
• Certified Clinical Psychopharmacologist

SELECT HONORS & AWARDS

• 2024 – M.B. Sterman Career Achievement Award – ISNR
• 2020 – Fellow – International Society of Neuroregulation and Research
• 2017 – Joel Lubar Award – ISNR
• 2007 – Fellow – National Academy of Neuropsychology
• Multiple NIH and Foundation Grant Collaborations

SELECTED PUBLICATIONS & CONTRIBUTIONS

• Cantor, D.S. & Evans, J. (Eds.) Clinical Methods of Neurotherapy. Academic Press, 2014.
• Cantor, D.S. An Overview of Quantitative EEG and Its Applications to Neurofeedback. Academic Press, 1999.
• Cantor, D.S. et al. International QEEG Certification Board / ECNS Guideline: Minimum technical requirements for performing clinical quantitative electroencephalography. Clinical EEG and Neuroscience, 2025.
• Edelson, S. & Cantor, D. (1998). Autism: Xenobiotic Influences. Toxicology and Industrial Health.
• Cantor, D.S. & Chabot, R. (2009). QEEG studies in Assessment and Treatment of Childhood Disorders. Clinical EEG and Neuroscience.

SELECTED INTERNATIONAL PRESENTATIONS & LECTURES

• Keynote Speaker – ISNR 2024: Consciousness and Adaptation: Quantum Theory and Beyond
• Invited Symposium – ECNS/ISNIP Joint Conference 2020: Clinical Use of Neuromodulation
• Keynote – International Conference of Biofeedback – Brazil 2013
• Panel Speaker – AAPB Conference 2025: Frontal Gamma Asymmetry as Forensic Tool
• International Lecture – Applied Neuroscience Society of Australasia 2018

SPECIALIZED EXPERTISE

• Strategic Executive Leadership
• Regulatory and Clinical Advisory
• Neurotechnology & Product Development
• Forensic Neuroscience Consulting
• Quantitative EEG & Neuromodulation
• International Scientific Education